Global Coalition for Adaptive Research Announces That Regorafenib Has Completed Follow-up in the GBM AGILE Trial for Patients With Glioblastoma
SEPTEMBER 21, 2022 |
BUSINESSWIRE
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’s VT1021 in GBM AGILE Trial
JULY 6, 2022 |
BUSINESSWIRE
GBM AGILE Opens to Paxalisib in Europe
MAY 31, 2022 |
KAZIA THERAPEUTICS
Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma
MAY 27, 2022 |
PRNEWSWIRE
Global Coalition for Adaptive Research Announces the Discontinued Evaluation of Eritoran in REMAP-COVID
MAY 19, 2022 |
BUSINESSWIRE
Cure Brain Cancer Foundation invests in GBM AGILE, connecting Australians to an innovative clinical trial program to treat glioblastoma
FEBRUARY 22, 2022 |
CURE BRAIN CANCER FOUNDATION
Global Coalition for Adaptive Research Announces Key Updates on GBM AGILE Phase 2-3 Adaptive Platform Trial for Patients With Glioblastoma
JANUARY 18, 2022 |
BUSINESSWIRE
Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma
NOVEMBER 30, 2021 |
PRNEWSWIRE
GBM AGILE Opens to Paxalisib in Canada
NOVEMBER 29, 2021 |
KAZIA THERAPEUTICS
Ovarian CanceRx: New Innovative Clinical Research Effort Seeks to Accelerate the Development of New Treatments for Deadliest Gynecological Cancer
SEPTEMBER 23, 2021 |
BUSINESSWIRE
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
AUGUST 4, 2021 |
NEJM
Global Coalition for Adaptive Research Announces the Discontinued Evaluation of Apremilast in REMAP-COVID
July 12, 2021 |
BUSINESSWIRE
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
FEBRUARY 25, 2021 |
NEJM
Henry Ford Cancer Institute is First in the World to Activate Two New Treatments in GBM AGILE Trial for Glioblastoma
FEBRUARY 3, 2021 |
NEWSWISE
Implementation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 (REMAP-COVID) trial in a US health system—lessons learned and recommendations
JANUARY 28, 2021 |
BIOMED CENTRAL
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients
JANUARY 22, 2021 |
NATIONAL INSTITUTES OF HEALTH
Global Coalition for Adaptive Research, Kazia, and Kintara Announce Commencement of Kazia’s Paxalisib and Kintara’s VAL-083 in GBM AGILE Trial
JANUARY 6, 2021 |
BUSINESSWIRE
Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial
OCTOBER 26, 2020 |
BUSINESSWIRE
Kintara and the Global Coalition for Adaptive Research Execute Agreement for VAL-083’s Participation in the GBM AGILE Registrational Study
OCTOBER 21, 2020 |
PRNEWSWIRE
Kazia Executes Agreement to Commence GBM AGILE Pivotal Study
OCTOBER 16, 2020 |
Kazia Therapeutics
Corticosteroids Improve Survival in Critically Ill COVID-19 Patients
SEPTEMBER 2, 2020 |
EUREKALERT
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19. The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
SEPTEMBER 2, 2020 |
JAMA
Steroids Can Be Lifesaving for Covid-19 Patients, Scientists Report
SEPTEMBER 2, 2020 |
NEW YORK TIMES
REMAP-CAP to Partner With Eisai on Innovative Trial to Combat COVID
JUNE 30, 2020 |
BUSINESSWIRE
Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals’ VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme
JUNE 4, 2020 |
PRNEWSWIRE
Chasing a Cure for GBM: Investigators Test Multiple Regimens in Novel Trial
MAY 14, 2020 |
ONCLIVE
International trial uses AI to rapidly identify optimal Covid-19 treatments
APRIL 9, 2020 |
STAT
December 11, 2019 |
PRNEWSWIRE
Henry Ford Cancer Institute Enrolls First Patient in World’s Largest Brain Cancer Clinical Trial
AUGUST 14, 2019 |
BIO SPACE
Global Coalition for Adaptive Research’s Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer
June 19, 2019
BUSINESS WIRE
Global Coalition for Adaptive Research (GCAR) Appoints Jeffrey Tarrant to Board of Directors
JUNE 13, 2019 |
BUSINESS WIRE
FDA’s Woodcock Defends Accelerated Approvals and Talks of Culture Shift in Clinical Trials
JUNE 5, 2019 |
BIOPHARMA DIVE
New Funding & Partnership Bolsters Support for First Global Adaptive Clinical Trial Platform for Brain Cancer Patients
MAY 1, 2019 |
NATIONAL BRAIN TUMOR SOCIETY
Global Coalition for Adaptive Research (GCAR) Names Meredith Buxton Chief Operating Officer
JANUARY 31, 2019 |
GLOBAL COALITION FOR ADAPTIVE RESEARCH
National Brain Tumor Society Invests in GBM AGILE, the World’s First Global Adaptive Trial for Glioblastoma
JANUARY 16, 2019 |
NATIONAL BRAIN TUMOR SOCIETY
Bayer’s Regorafenib is the First Drug to Enter GBM AGILE
NOVEMBER 14, 2018 |
BUSINESSWIRE
Global Coalition for Adaptive Research (GCAR) Names Gary Gordon Interim Chief Executive Officer
NOVEMBER 8, 2018 |
PRWEB
4 Ways Cancer is Changing How We Test Medicines
OCTOBER 18, 2018 |
POLITICO
Dr. W.K. Alfred Yung Addresses Members of U.S. Congress at Glioblastoma Event Hosted by NBTS, Senator Lindsey Graham
May 16, 2018 |
National Brain Tumor Society
Global Coalition for Adaptive Research Launches to Speed the Discovery & Development of Cures for Patients with Rare & Deadly Diseases
April 16, 2018 |
BusinessWire
Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?
March 8, 2018 |
Harvard Business School
W.K. Alfred Yung, M.D. – Smart Bomb Virus Shows Promise as Brain Tumor Immunotherapy
FEBRUARY 12, 2018 |
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
Dr. Brian M. Alexander – Kraft Precision Medicine Accelerator has met with the US Food and Drug Administration to Discuss Standardizing Platform Methodologies
January 15, 2018 |
Harvard Business School
Joe Biden Recognizes Dr. W.K. Alfred Yung on The View
December 13, 2017 |
ABC’s ‘The View’
Advancing Oncology Platform Trials
December 12-13, 2017 |
Dr. Brian M. Alexander, MIT Next Wave Forum 2017
Dr. Webster K. Cavenee Elected to the Chinese Academy of Engineering
November 28, 2017 |
Chinese Academy of Engineering
Dr. Brian M. Alexander – Adaptive Platform Trials: The Clinical Trial of the Future?
September 26, 2017 |
Ariel D. Stern and Sarah Mehta, Harvard Business Review
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE
September 20, 2017 |
Dr. Brian M. Alexander, Dr. Sujuan Ba, Dr. Webster Cavenee, Dr. Timothy F. Cloughesy, Dr. W.K. Alfred Yung – American Association for Cancer Research
Dr. Sujuan Ba Wins International Cooperation Award from the Chinese Medical Doctor Association
March 27, 2017 |
NATIONAL FOUNDATION FOR CANCER RESEARCH
Dr. W.K. Alfred Yung Presents Joe Biden, Dr. Jill Biden With Commemorative Plaque at MD Anderson’s Diamond Gala
November 17, 2016 |
University of Texas MD Anderson Cancer Center
Dr. Webster K. Cavenee Receives 2016 Chinese Government Friendship Award
September 28, 2016 |
Chinese Vice Premier Ma Kai
The Billion Dollar Statistical Concept
August 10, 2016 |
Dr. Scott Berry
I-SPY 2 and Other Platform Trials
May 1, 2015 |
Dr. Don Berry
The Adaptive Platform Trial – The Statistical Efficiencies
March 6, 2015 |
Dr. Scott Berry